Signal transduction of erythropoietin in endothelial cells

被引:75
作者
Haller, H
Christel, C
Dannenberg, L
Thiele, P
Lindschau, C
Luft, FC
机构
[1] Franz Volhard Clinic, 13122 Berlin
关键词
D O I
10.1038/ki.1996.339
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Erythropoietin (EPO) induces endothelin expression in endothelial cells (EC) and has angiogenic effects. We investigated the intracellular signal transduction of EPO in EC and tested the hypothesis that the proliferative effects of EPO may be mediated by cytosolic calcium, changes in intracellular pH, or tyrosine phosphorylation. Cytosolic calcium and pH were measured with fura-2 and BCECF. Protein phosphorylation was assessed with P-32-labeled EC and two-dimensional (2D) gel chromatography. Tyrosine phosphorylation was measured using specific antityrosine antibodies and confocal microscopy. Proliferation was measured by thymidine incorporation and cell count. No effects of EPO on cytosolic calcium and pH were observed. In contrast, erythropoietin increased phosphorylation of 94, 70, 42, 40, 29 and 25 kDa proteins at five minutes and 60 minutes. Most of the early proteins were tyrosine phosphorylated. Confocal microscopy showed cytosolic as well as membrane-bound tyrosine phosphorylation in resting cells and an EPO-induced translocation of immunoreactivity to the nucleus. Immunostaining for the transcription factor STAT-5 showed that EPO induced a nuclear translocation of STAT-5. EPO 0.5, 2, and 4 U/ml increased proliferation, an effect that was prevented by incubation with the tyrosine kinase inhibitor genistein. We conclude that EPO induces proliferation in EC initially via tyrosine phosphorylation of six distinct proteins, and that the phosphorylation and nuclear translocation of the transcription factor STAT-5 is important for the effects of EPO on EC.
引用
收藏
页码:481 / 488
页数:8
相关论文
共 50 条
[1]  
ABDELLATIF AA, 1986, PHARMACOL REV, V38, P227
[2]   ERYTHROPOIETIN HAS A MITOGENIC AND POSITIVE CHEMOTACTIC EFFECT ON ENDOTHELIAL-CELLS [J].
ANAGNOSTOU, A ;
LEE, ES ;
KESSIMIAN, N ;
LEVINSON, R ;
STEINER, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (15) :5978-5982
[3]   ERYTHROPOIETIN RECEPTOR MESSENGER-RNA EXPRESSION IN HUMAN ENDOTHELIAL-CELLS [J].
ANAGNOSTOU, A ;
LIU, ZY ;
STEINER, M ;
CHIN, K ;
LEE, ES ;
KESSIMIAN, N ;
NOGUCHI, CT .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (09) :3974-3978
[4]   IDENTIFICATION OF JAK2 AS A GROWTH-HORMONE RECEPTOR-ASSOCIATED TYROSINE KINASE [J].
ARGETSINGER, LS ;
CAMPBELL, GS ;
YANG, XN ;
WITTHUHN, BA ;
SILVENNOINEN, O ;
IHLE, JN ;
CARTERSU, C .
CELL, 1993, 74 (02) :237-244
[5]   COLONY-STIMULATING FACTORS AND INTERFERON-GAMMA ACTIVATE A PROTEIN RELATED TO MGF-STAT-5 TO CAUSE FORMATION OF THE DIFFERENTIATION-INDUCED FACTOR IN MYELOID CELLS [J].
BARAHMANDPOUR, F ;
MEINKE, A ;
EILERS, A ;
GOUILLEUX, F ;
GRONER, B ;
DECKER, T .
FEBS LETTERS, 1995, 360 (01) :29-33
[6]  
BARBER DL, 1992, SEMIN HEMATOL, V29, P293
[7]   ENDOTHELIN RELEASE AND SHIFT IN PROSTAGLANDIN BALANCE ARE INVOLVED IN THE MODULATION OF VASCULAR TONE BY RECOMBINANT ERYTHROPOIETIN [J].
BODEBOGER, SM ;
BOGER, RH ;
KUHN, M ;
RADERMACHER, J ;
FROLICH, JC .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1992, 20 :S25-S28
[8]   ERYTHROPOIETIN DOES NOT INDUCE VASOCONSTRICTION DIRECTLY IN HUMAN SUBCUTANEOUS RESISTANCE ARTERIOLES [J].
BUND, SJ ;
HEAGERTY, A ;
EDMUNDS, M ;
WALLS, J .
NEPHRON, 1989, 53 (02) :173-173
[9]   ANTIPLATELET THERAPY AND DEVELOPMENT OF HYPERTENSION INDUCED BY RECOMBINANT-HUMAN-ERYTHROPOIETIN IN UREMIC PATIENTS [J].
CARAVACA, F ;
PIZARRO, JL ;
ARROBAS, M ;
CUBERO, JJ ;
GARCIA, MC ;
PEREZMIRANDA, M .
KIDNEY INTERNATIONAL, 1994, 45 (03) :845-851
[10]   RECOMBINANT-HUMAN-ERYTHROPOIETIN (RHUEPO) INCREASES ENDOTHELIN-1 RELEASE BY ENDOTHELIAL-CELLS [J].
CARLINI, RG ;
DUSSO, AS ;
OBIALO, CI ;
ALVAREZ, UM ;
ROTHSTEIN, M .
KIDNEY INTERNATIONAL, 1993, 43 (05) :1010-1014